Nanjing Well Pharmaceutical Group Co. Ltd.SSE: 603351

2025 Semi-annual Report

Aug 20, 2025 · Issued by Nanjing Well Pharmaceutical Group Co. Ltd. via Shanghai Stock Exchange

Filed with SSE · Aug 20, 2025

On 6ix: 6ix.com/news/2025-semi-annual-report-303

2025 Semi-annual Report

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

Nanjing Well Pharmaceutical Group Co. Ltd. on 6ix

Earlier from Nanjing Well Pharmaceutical

Announcement on Pledge and Release of Pledge of Shares of Shareholder with Over 5% SharesAug 19, 2025
Announcement on Implementation of Dividend Distribution for 2024Jun 6, 2025
Announcement on Resolutions of the 2024 Annual General MeetingMay 16, 2025
Announcement on Convening the 2024 Annual and Q1 2025 Performance BriefingApr 30, 2025
Announcement on Risk Warning in Stock TradingApr 23, 2025

Later from Nanjing Well Pharmaceutical

Announcement on Pledge of Shares of Shareholder with Over 5% SharesAug 21, 2025
Announcement on Release of Pledge and Period Extension of Shares of Shareholder with Over 5% SharesAug 26, 2025
Announcement on Outline of the 2025 Semi-annual Performance BriefingAug 29, 2025
Indicative Announcement on Change in Equity of Shareholders with Over 5% Shares Reaching 1% ScaleOct 24, 2025
Notice on Convening the 1st Extraordinary General Meeting in 2025Oct 30, 2025

All Nanjing Well Pharmaceutical news releases

Follow Nanjing Well Pharmaceutical into a list and get an email when it puts out news.

Follow Nanjing Well Pharmaceutical